BioTelemetry Inc

Find Ratings Reports
BEAT : NASDAQ : Health Care
$28.85 | %
Today's Range: 0.0 - 0.0
Avg. Daily Volume: 514600.0
05/23/17 - 4:00 PM ET

Financial Analysis


BIOTELEMETRY INC's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased. BIOTELEMETRY INC has strong liquidity. Currently, the Quick Ratio is 1.67 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

At the same time, stockholders' equity ("net worth") has greatly increased by 77.17% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)55.8848.64
EBITDA ($mil)9.328.22
EBIT ($mil)5.64.95
Net Income ($mil)0.24.1


Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)25.122.84
Total Assets ($mil)204.58128.93
Total Debt ($mil)25.1323.24
Equity ($mil)142.9180.66


Profitability Q1 FY17 Q1 FY16
Gross Profit Margin63.7668.29
EBITDA Margin16.6616.89
Operating Margin10.0210.18
Sales Turnover1.051.42
Return on Assets24.218.99
Return on Equity34.6614.37
Debt Q1 FY17 Q1 FY16
Current Ratio1.892.13
Debt/Capital0.150.22
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)28.6327.64
Div / share0.00.0
EPS0.010.14
Book value / share4.992.92
Institutional Own % n/a n/a
Avg Daily Volume518510.0283983.0

Valuation


BUY. This stock's P/E ratio indicates a discount compared to an average of 22.94 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 25.02. For additional comparison, its price-to-book ratio of 5.50 indicates a significant premium versus the S&P 500 average of 3.00 and a significant premium versus the industry average of 3.31. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
BEAT 17.16 Peers 22.94   BEAT 22.12 Peers 11.23

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

BEAT is trading at a significant discount to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

BEAT is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
BEAT 25.65 Peers 16.12   BEAT NM Peers 1.27

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

BEAT is trading at a significant premium to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

BEAT's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
BEAT 5.50 Peers 3.31   BEAT 300.00 Peers 17.26

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

BEAT is trading at a significant premium to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

BEAT is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
BEAT 3.65 Peers 0.86   BEAT 17.33 Peers 10.61

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

BEAT is trading at a significant premium to its industry.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

BEAT has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades